These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 6972989)

  • 1. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
    Chang YH; Pearson CM; Chedid L
    J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition.
    Kohashi O; Tanaka A; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S; Ozawa A
    Infect Immun; 1980 Jul; 29(1):70-5. PubMed ID: 7399708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muramyl dipeptide-induced adjuvant arthritis.
    Nagao S; Tanaka A
    Infect Immun; 1980 May; 28(2):624-6. PubMed ID: 7399679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.
    Kohashi O; Aihara K; Ozawa A; Kotani S; Azuma I
    Lab Invest; 1982 Jul; 47(1):27-36. PubMed ID: 7087395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.
    Kohashi O; Kotani S; Shiba T; Ozawa A
    Infect Immun; 1979 Nov; 26(2):690-7. PubMed ID: 546792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient induction of collagen arthritis by the use of a synthetic muramyl dipeptide.
    Koga T; Sakamoto S; Onoue K; Kotani S; Sumiyoshi A
    Arthritis Rheum; 1980 Sep; 23(9):993-7. PubMed ID: 7417362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of drugs in rats treated with a synthetic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
    Zídek Z; Kameníková L; Buchar E; Janků I; Masek K
    Int J Immunopharmacol; 1983; 5(2):151-5. PubMed ID: 6874168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
    Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
    Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.
    Tanaka A; Saito R; Sugiyama K; Morisaki I; Kotani S
    Infect Immun; 1977 Jan; 15(1):332-4. PubMed ID: 832904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats.
    Kohashi O; Pearson CM; Tamaoki N; Tanaka A; Shimamura K; Ozawa A; Kotani S; Saito M; Hioki K
    Infect Immun; 1981 Feb; 31(2):758-66. PubMed ID: 7012019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
    Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
    Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
    Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
    Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
    Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.